Wilhelm Uhthoff
German ophthalmologist
Wilhelm Uhthoff (31 July 1853 – 21 March 1927) was a notable German ophthalmologist known for his contributions to the understanding of neurological and visual disorders. His work primarily focused on the relationship between optic neuritis and multiple sclerosis.
Early Life and Education[edit | edit source]
Wilhelm Uhthoff was born in Klein Warin, Mecklenburg-Schwerin, Germany. He pursued his medical studies at the University of Berlin, where he developed a keen interest in ophthalmology. After completing his education, Uhthoff worked under several prominent physicians, which helped him refine his skills and knowledge in the field.
Career[edit | edit source]
Uhthoff began his career as an assistant at the University of Jena, where he worked in the ophthalmology clinic. His dedication and expertise soon led him to a professorship at the University of Breslau (now Wrocław, Poland), where he spent the majority of his career.
During his tenure at Breslau, Uhthoff conducted extensive research on the effects of optic neuritis and its association with multiple sclerosis. He is best known for describing what is now called "Uhthoff's phenomenon," a temporary worsening of neurological symptoms, particularly visual disturbances, in patients with multiple sclerosis when they become overheated.
Uhthoff's Phenomenon[edit | edit source]
Uhthoff's phenomenon is characterized by a temporary decrease in visual acuity and other neurological functions in response to an increase in body temperature. This can occur due to physical exercise, fever, or exposure to hot environments. Uhthoff's observations were crucial in understanding the pathophysiology of multiple sclerosis and its impact on the optic nerve.
Legacy[edit | edit source]
Wilhelm Uhthoff's contributions to medicine, particularly in the field of neuro-ophthalmology, have had a lasting impact. His work laid the foundation for further research into the relationship between neurological disorders and visual symptoms. Uhthoff's phenomenon remains a significant consideration in the diagnosis and management of multiple sclerosis today.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
